These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4526246)

  • 1. Some observations on the use of chemically labelled normal white blood cells as antigens in active immunization of leukaemia.
    Sahasrabudhe MB; Madyastha KR; Prema S; Gollerkeri MP
    Biomedicine; 1974 Jan; 20(1):31-9. PubMed ID: 4526246
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the use of chemically tagged normal white blood cells as antigens for producing specific immune response against human leukemic cells.
    Sahasrabudhe MB; Prema S; Madyastha KR; Gollerkeri MP
    Indian J Cancer; 1972 Jun; 9(2):101-11. PubMed ID: 4629010
    [No Abstract]   [Full Text] [Related]  

  • 3. Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia.
    Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
    Biomed Pharmacother; 2007 Jul; 61(6):306-14. PubMed ID: 17368821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibody-dependent cellular cytotoxicity (AAZZ) against leukemia cells--K-cell activity of human leukocytes].
    Thränhardt H; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):824-40. PubMed ID: 6162750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R
    Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
    [No Abstract]   [Full Text] [Related]  

  • 6. [Some aspects of the disturbances of humoral and cellular immunological barrier in leukemia patients].
    Szmigiel Z
    Przegl Lek; 1973; 30(6):514-7. PubMed ID: 4581660
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetics of appearance of anti HL-A antibodies no binding C' (blocking)].
    Colombani J; Pavie-Fischer J; Kourilsky RM
    C R Seances Soc Biol Fil; 1974; 168(2-3):187-92. PubMed ID: 4282271
    [No Abstract]   [Full Text] [Related]  

  • 8. Isohaemagglutinin anti-A and anti-B, and serum complement levels in children with leukaemia.
    Kubiková-Kourilová A; Bĕlusa M
    Acta Paediatr Acad Sci Hung; 1970; 11(3):319-22. PubMed ID: 5525405
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy for chronic granulocytic leukaemia.
    Sokal JE
    Clin Haematol; 1977 Feb; 6(1):129-39. PubMed ID: 334405
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy of acute myeloid leukemia: current approaches.
    Smits EL; Berneman ZN; Van Tendeloo VF
    Oncologist; 2009 Mar; 14(3):240-52. PubMed ID: 19289488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.
    Pullen S; Hersey P
    Clin Exp Immunol; 1980 Feb; 39(2):403-10. PubMed ID: 6966993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in well-controlled chronic myelocytic leukemia.
    Sokal JE; Aungst CW; Grace JT
    N Y State J Med; 1973 May; 73(10):1180-5. PubMed ID: 4512241
    [No Abstract]   [Full Text] [Related]  

  • 13. [Importance of immunological phenomena in sterility].
    Matte J
    Union Med Can; 1970 Dec; 99(12):2252-3. PubMed ID: 5488655
    [No Abstract]   [Full Text] [Related]  

  • 14. The favourable effect of immunotherapy on survival and the achievement of a second remission in acute myeloid leukaemia.
    Storms GE; Burghouts J; Haanen C
    Neth J Med; 1980; 23(2):54-8. PubMed ID: 6929412
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation.
    Mehta J; Powles R; Singhal S; Tait D; Swansbury J; Treleaven J
    Bone Marrow Transplant; 1995 Jul; 16(1):133-7. PubMed ID: 7581113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active immunotherapy in spontaneous leukemia of AkR mice.
    Mathé G; Halle-Pannenko O; Bourut C
    Exp Hematol; 1973; 1(2):110-4. PubMed ID: 4609352
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody-targeted therapy for myeloid leukemia.
    Appelbaum FR
    Semin Hematol; 1999 Oct; 36(4 Suppl 6):2-8. PubMed ID: 10530710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.
    Schneerson R; Rodrigues LP; Parke JC; Robbins JB
    J Immunol; 1971 Oct; 107(4):1081-9. PubMed ID: 5315273
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of chronic myelocytic leukemia.
    Sokal JE; Aungst CW; Grace JT
    Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasmapheresis as an auxiliary method in the immunotherapy of chronic myelosis].
    Smálik S; Filová J
    Cas Lek Cesk; 1970 Mar; 109(11):246-50. PubMed ID: 5270441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.